Literature DB >> 11161992

Effects of Glyptapanteles liparidis (Hym.: Braconidae) parasitism, polydnavirus, and venom on development of microsporidia-infected and uninfected Lymantria dispar (Lep.: Lymantriidae) larvae.

G Hoch1, A Schopf.   

Abstract

Effects of parasitism, polydnavirus, and venom of the endoparasitoid Glyptapanteles liparidis on Lymantria dispar larvae infected with the microsporidium Vairimorpha sp. and uninfected hosts were studied. We tested the impact on growth and development of hosts, as well as on microsporidian infection. Both parasitism and polydnavirus/venom treatment alone caused a slight increase in growth rate and relative growth rate in uninfected fourth instar hosts. This effect was more pronounced with the addition of Vairimorpha infection. With no parasitism, however, infection reduced host growth markedly. Microsporidiosis delayed larval molts of L. dispar, and additional polydnavirus/venom treatment or parasitization induced significantly earlier molting. Polydnavirus/venom treatment of uninfected L. dispar resulted in prolonged larval development due to supernumerary molts and in higher pupal mortality. Infected larvae treated with polydnavirus/venom died earlier than infected larvae that were not treated and produced more Vairimorpha spores per unit fresh mass of the host.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161992     DOI: 10.1006/jipa.2000.4987

Source DB:  PubMed          Journal:  J Invertebr Pathol        ISSN: 0022-2011            Impact factor:   2.841


  2 in total

1.  Protein Discovery: Combined Transcriptomic and Proteomic Analyses of Venom from the Endoparasitoid Cotesia chilonis (Hymenoptera: Braconidae).

Authors:  Zi-Wen Teng; Shi-Jiao Xiong; Gang Xu; Shi-Yu Gan; Xuan Chen; David Stanley; Zhi-Chao Yan; Gong-Yin Ye; Qi Fang
Journal:  Toxins (Basel)       Date:  2017-04-12       Impact factor: 4.546

2.  Lack of phenotypic and evolutionary cross-resistance against parasitoids and pathogens in Drosophila melanogaster.

Authors:  Alex R Kraaijeveld; Sophie J Layen; Peter H Futerman; H Charles J Godfray
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.